A highly potent and safe pyrrolopyridine-based allosteric HIV-1 integrase inhibitor targeting host LEDGF/p75-integrase interaction site is a research paper published in PLoS Pathogens (2021). On theSindex it has a DataRank of 0. It has been cited 39 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Allergy and Infectious Diseases
Grant: AI141327
National Institute of Allergy and Infectious Diseases
Grant: AI143649
National Institute of Allergy and Infectious Diseases
Grant: AI039394
NIAID NIH HHS
Grant: R01 AI039394
NIAID NIH HHS
Grant: R01 AI062520
NIAID NIH HHS
Grant: R01 AI143649
NIAID NIH HHS
Grant: R37 AI039394
NIAID NIH HHS
Grant: R01 AI141327
National Institutes of Health
Grant: 5R01AI039394-13
Biochemical Mechanism of HIV DNA Integration
National Institutes of Health
Grant: 5R01AI143649-05
Multimeric HIV-1 Integrase Inhibitors
National Institutes of Health
Grant: 5R01AI141327-07
Structural and Chemical Analysis of Highly Potent ALLINI Platform
Research contract, ST Pharm, Ltd
FWCI
1.55
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals